Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Carboplatin|DRUG: Gemcitabine|DRUG: Nadunolimab
Sponsor: Cantargia AB
Collaborators: Spanish Breast Cancer Research Group